A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis

Rheumatology International

Volumn 26, Issue 4, 2006, Pages 325-330

  Kotevoglu, Nurdan ^a   Iyibozkurt, Pinar Cakil ^a   Hiz, Ozcan ^a   Toktas, Hasan ^a   Kuran, Banu ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Hyaluronic acid; Knee osteoarthritis; Viscosupplementation

Indexed keywords

HYALURONIC ACID; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MOLECULAR WEIGHT; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RIGIDITY; SCORING SYSTEM; STATISTICAL ANALYSIS; UNSPECIFIED SIDE EFFECT; VISCOSITY;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; RANGE OF MOTION, ARTICULAR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 30744479437     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0611-0     Document Type: Article

References (28)

1. Adams ME, Atkinson MH, Lussier AJ et al (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee : a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal antiinflammatory drugs (NSAIs) and NSAIDs alone. Osteoarthritis Cartilage 3:213-226
2. Balazs EA, Watson D, Duff IF, Roseman S (1967) Hyaluronic acid in synovial fluid I. Molecular parameters of hyaluronic acid in normal and arthritic human synovial fluid. Arthritis Rheum 10:357-376
3. Wobig M, Bach G, Beks P, Dickhut A et al (1999) The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 21:1549-1559
4. Altman R, Asch E, Bloch D et al (1986) Development of critria fot the classification and reporting of osteoarthritis Classification of osteoarthritis of the Knee Diagnostic and Therapeutic Committee of the American Rheumatism Aassociation. Arthritis Rheum 29:1039-1049
5. Lawrence JS, Bremmmer JM, Bier F (1996) Osteoarthritis prevelance in the population and relationship between symptoms and X-ray changes. Ann Rheum Dis 25:1-24
6. Bellamy N (1995) WOMAC osteoarthritis index: a users guide. London, Ontario, Victoria Hospital
7. Adams ME, Lussier AJ, Peyron JG (2000) A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Safety 23:115-130
8. Balazs EA (1982) The physical properties of synovial fluid and the special role of hyaluronic acid. In: Helfet AJ (ed) Disorders of the knee, 2nd edn. JB Lippincott, Philadelphia, pp 61-74
9. Wobig M, Dickhut A, Maier R, Vetter G (1998) Viscosupplementation with hylan G-F20: a 26-week controlled trial of efficacy and safety in the osteoarthritis knee. Clin Ther 20:410-423
10. Rydell N, Balazs EA (1971) Effect of intraarticular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthop 80:25-32
11. Smith MM, Ghosh P (1987) Synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of hyaluronate in the extracellular environment. Rheumatol Int 7:113-122
12. Aviad AD, Houpt JB (1994) The molecular weight of theurapeutic hyaluronan (sodium hyaluronate): how significant is it? J Rheumatol 21:297-301
13. Goorman SD, Watanabe TK, Miller EH, Perry C (2000) Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study. Arch Phys Med Rehabil 81(4):479-483
14. Altman RD, Moskowitz RW, The Hyalgan Study Group (1998) Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 25:2203-2212
15. Kolarz G, Kotz R, Hochmayer I (2003) Long term benefits and repeated treatment cycles of intraarticular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 32(5):310-319
16. Puttick MPE, Wade JP, Chalmers A, Connell DG, Rangno KK (1995) Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 22:1311-1314
17. Weiss C, Band P (1995) Musculoskeletal applications of hyaluronan and hylan. Clin Pod Med Surg 12:497-517
18. Lussier A, Cividino AA, Mc Farlane CA et al (1996) Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 23(9):1579-1585
19. Controzier T, Mathieu P, Schott AM et al (2003) Factors predicting long term efficacy of Hylan G-F 20 viscosupplementation in knee osteoarthritis. Joint Bone Spine 70(2):128-133
20. Jackson DW, Evans NA, Thomas BM (2002) Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 84(9):1522-1527
21. Karlsson J, Sjögren LS, Lohmander LS (2002) Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double blind, parallel design multicentre study. Rheumatology 41(11):1240-1248
22. Tang SF, Chen CP, Chen MC, Pei YC, Lau YC, Leong CP (2004) Changes in saggital ground reaction forces after intraarticular hyaluronate injections for knee osteoarthritis. Arch Phys Med Rehabil 85(6):951-955
23. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM (2004) Theraeutic effects of hyaluronic acid on osteoarthritis of the knee. A metaanalysis of randomized controlled trials. J Bone Joint Surg Am 86(3):538-545
24. Lo GH, La Valley M, Mc Alindon T, Felson DT (2003) Intraarticular hyaluronic acid in treatment of knee osteoarthritis: a metaanalysis. JAMA 290(23):3115-3121
25. Moreland LW (2003) Intraarticular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanism of action. Arthritis Res Ther 5(2):54-67
26. Ghosh P, Guidolin D (2002) Potential mechanism of action of intraarticular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 32(1):10-37
27. Frizziero L, Govoni E, Bacchini P (1998) Intraarticular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 16(4):441-449
28. Pasquali Ronchetti I, Guerra D, Taparelli F, Boraldi F, Bergamini G, Mori G, Zizzi F, Frizziero L (2001) Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology 40(2):158-169